Repurposing a proven gene therapy approach to treat, prevent COVID-19

In a Q&A, Penn Medicine’s James M. Wilson discusses using adeno-associated viral vectors to transport a lab-made antibody cocktail into the body. This method, delivered via nasal spray or mist, has the potential to act as a ‘bioshield’ against SARS-CoV-2.

Read More in Penn Today

Skip to content